ReviewClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026
Cuproptosis: potential new direction in liver-related diseases research and treatment.
Review in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cell death is critical for the onset and progression of liver diseases, as well as organismal growth and development. It can be broadly classified into regulated cell death and accidental cell death. Ferroptosis and cuproptosis are metal-dependent cell death processes that play important roles in disease management. Disrupted copper homeostasis, whether due to copper excess or deficiency, is strongly associated with the development of various diseases. Cuproptosis is a newly identified form of cell death characterized by excessive accumulation of copper inside cells. The liver is the primary organ for copper storage. Triggering cuproptosis in liver cells represents an innovative therapeutic strategy to treat liver diseases. This review outlines the cellular and molecular mechanisms and characteristics of cuproptosis and the links of the novel regulated cell death modality with liver-related diseases. We also review the current knowledge on the complex effects of cuproptosis on liver therapeutic strategies. As well as discussing future research directions that may lead to major advances in the prevention, intervention and treatment of liver-related diseases.
Indexed as
Identifiers
42230529What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.